ClinConnect ClinConnect Logo
Search / Trial NCT03524209

CORset Versus OstéoSynthese in Adult Pyogenic Spondylodiscitis

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · May 11, 2018

Trial Information

Current as of July 04, 2025

Unknown status

Keywords

Spondylodiscitis Spinal Infection Back Pain Quality Of Life Fusion Minimal Invasive Surgery Brace Treatment

ClinConnect Summary

Safety and efficacy of percutaneous for the indication of pyogenic spondylitis has been demonstrated retrospectively on small cohort studies, which is in line with our clinical experience. Although this therapeutic concept seems applicable to patients with spondylitis, the theoretical clinical benefit of minimally invasive surgery remains hypothetic and unclear compared to brace treatment, which might still be regarded as the gold standard.

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • adult patients presenting acute pyogenic spondylitis of the thoracolumbar spine
  • back pain at a minimum of 4 out of 10 on VAS
  • Diagnostic MRI and disc puncture + microbiological analysis required for antibiotic treatment and/or blood culture
  • Vertebral body involvement (osteolysis) \< 50% of VB height documented on CT
  • Exclusion criteria:
  • postoperative pyogenic spondylitis or infection after spinal instrumentation spinal tuberculosis and mycosis
  • contra-indications for surgery or general anaesthesia
  • general septic conditions acute endocarditis documented by sonography
  • patients presenting another major abcess or an epidural abscess
  • Absence of vertebral body involvement (osteolysis) on CT or minor VB involvement less than 10% of VB height (surgery not indicated)
  • Major destruction of vertebral body (\>50%) on CT (surgery mandatory) Patients with concomitant bacterial endocarditis

About University Hospital, Strasbourg, France

The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.

Locations

Caen, , France

Grenoble, , France

Bordeaux, , France

Clichy, , France

Dijon, , France

Lyon, , France

Marseille, , France

Montpellier, , France

Nancy, , France

Nantes, , France

Nice, , France

Paris, , France

Paris, , France

Reims, , France

Strasbourg, , France

Patients applied

0 patients applied

Trial Officials

Yann Philippe CHARLES, MD

Principal Investigator

Hôpitaux Universitaires de Strasbourg - Service de chirurgie du rachis

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials